Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sickweather was a U.S. digital health and disease-intelligence company that developed an AI-enabled, hyperlocal illness forecasting and mapping platform. Its products used social listening, crowdsourced symptom reports, and third-party data sources to generate real-time sickness alerts, heat maps, and forward-looking outbreak forecasts for consumers and enterprise users. The company positioned itself as a "Doppler radar for illness" and marketed mobile-app alerts as well as data/API services for infectious-disease monitoring. Although it operated commercially and raised venture and crowdfunding capital, more recent company-profile sources indicate the business is out of operation and underwent liquidation proceedings in December 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sickweather.